Forty-three patients with Klebsiella oxytoca bacteremia were seen between July 1980 and June 1996 at National Taiwan University Hospital (Taipei, Taiwan). We retrospectively analyzed the clinical features of these patients and the antimicrobial susceptibilities of the 43 isolates recovered from them. Twenty-seven patients (63%) had community-acquired bacteremia, and 16 patients (37%) had polymicrobial bacteremia. The clinical syndromes included hepatobiliary infections (58% of patients), primary bacteremia (23%), intravascular device -associated infections (7%), urinary tract infections (5%), skin and soft-tissue infections (5%), and peritonitis (2%). Most of these patients (93%) had underlying diseases including hepatobiliary diseases (53%), neoplastic diseases (42%), and diabetes mellitus (16%). Eight patients (19%) had septic shock, and two (5%) had disseminated intravascular coagulation. Four patients (9%) died of K. oxytoca bacteremia. All isolates were susceptible to ampicillin/sulbactam, cefmetazole, imipenem, aminoglycosides, and quinolones, and 86% of the isolates were susceptible to cefazolin.
Klebsiella bacteremia is associated with high rates of morfor isolation of K. oxytoca during a 16-year period (July 1980 through June 1996 . The hospital is a 2,000-bed teaching facility bidity and mortality, and Klebsiella species have been responsible for nosocomial outbreaks of infections, particularly in intenthat serves as both a primary care and a tertiary referral center in northern Taiwan. We retrospectively reviewed the medical sive care units [1, 2] . Most of the Klebsiella strains implicated in invasive infections have been K. pneumoniae [3] . However, records of all patients whose blood cultures were positive for K. oxytoca. We collected and analyzed the following informathe frequency of isolation of the indole-positive Klebsiella species K. oxytoca has recently increased [4] . The emergence of tion: demographic data, underlying diseases, clinical manifestations of K. oxytoca bacteremia, predisposing factors for the infecstrains of K. pneumoniae as well as K. oxytoca that are resistant to extended-spectrum b-lactam antibiotics makes the choice of tion, first in-hospital day that blood cultures were positive for K. oxytoca, the presence of polymicrobial bacteremia, sources an appropriate antimicrobial agent for treating infections caused by these organisms difficult [5] .
of K. oxytoca other than blood, antibiotic regimens based on blood culture results, complications, and outcomes. Most reports of Klebsiella bacteremia included only K. pneumoniae for analysis. No differences with respect to the clinical Definitions. K. oxytoca bacteremia was defined as the isolation of K. oxytoca in one or more blood cultures in association features and antimicrobial susceptibilities of the isolates have been reported to exist between K. pneumoniae and other species with clinical features of bacteremia and/or sepsis. All patients whose positive blood culture results were obtained on or after of Klebsiella [3, 6] . To study the clinical characteristics of patients with K. oxytoca bacteremia and the antimicrobial susthe third day of hospitalization were considered to have nosocomial bacteremia. An episode of K. oxytoca bacteremia was ceptibilities of the isolates, we retrospectively reviewed 43 cases of K. oxytoca bacteremia that occurred over a 16-year considered to be community acquired if the organism was isolated from cultures of blood obtained within 48 hours of hospiperiod at National Taiwan University Hospital (Taipei, Taiwan).
talization. Primary bacteremia was defined as bacteremia without an obvious source. If it occurred in patients with intravascular Patients and Methods catheters, these patients were included only if there were no Clinical features. We reviewed the records of the clinical local symptoms and signs of inflammation at the catheter insermicrobiology laboratory at National Taiwan University Hospital tion site. Intravascular device -associated infection was defined as local symptoms and signs of inflammation at the site of catheter insertion and as the isolation of K. oxytoca from at been performed within 1 month before the onset of K. oxytoca (n Å 10), Enterococcus faecalis (n Å 3), Enterobacter cloacae (n Å 2), and Proteus mirabilis (n Å 1). bacteremia. Prior antimicrobial therapy was defined as the receipt of antimicrobial agents within the 2 weeks before the The ages of patients ranged from 5 years to 93 years (mean age { SD, 55.3 { 20 years). Seventy-seven percent were ú40 onset of K. oxytoca bacteremia. The portals of entry of bacteremia were defined clinically and/or from the isolation of years of age, and 47% were ú60 years of age. The male-tofemale ratio was 1.9:1. Fifty-one percent of the patients had K. oxytoca from the site of entry.
Shock was defined as a decrease in systolic blood pressure been admitted to medical units, 44% had been admitted to surgical units, and 5% had been admitted to pediatric wards. to a level of õ90 mm Hg or as a decrease of §30 mm Hg below the baseline blood pressure. Jaundice secondary to bacThe common underlying diseases associated with K. oxytoca bacteremia were hepatobiliary diseases (53% of patients), neoteremia was defined as a total serum bilirubin level of §2.0 mg/dL in a patient without known preexisting hepatobiliary plastic diseases (42%), and diabetes mellitus (16%) (table 1). Thirteen (30%) of these patients had received antimicrobial disease or as an increase of §2 mg/dL over the baseline of the total serum bilirubin level in a patient with hepatobiliary agents before the onset of K. oxytoca bacteremia. All prior antimicrobial agents used were not effective against the corredisease. Chronic renal insufficiency was defined as a serum creatine level of ú2 mg/dL before or at the time of K. oxytoca sponding isolates, although none of the isolates from patients who received prior antimicrobial therapy were resistant to cefobacteremia. Alcoholism was defined as daily consumption of alcohol (ú80 g) for a minimum of 2 years before onset of the taxime or aztreonam. Eight patients (19%) had indwelling urinary catheters iminfection.
Leukocytosis was defined as a WBC count of ú10,000/mm 3 , planted or had undergone recent urinary manipulations, and two of these patients developed K. oxytoca bacteremia secondary leukopenia was defined as a WBC count of õ4,000/mm 3 , and thrombocytopenia was defined as a platelet count of õ100,000/ to urinary tract infection. Eleven patients (26%) had received immunosuppressive therapy, including six (14%) who had remm 3 . Disseminated intravascular coagulation (DIC) was defined as the presence of at least the following abnormalities:
ceived chemotherapy for neoplastic disease and five (12%) who had received steroid therapy. Six of these patients developed thrombocytopenia, a plasma fibrinogen level of õ150 mg/dL, a positive test for fibrin degradation products, and prolonged primary K. oxytoca bacteremia. Four patients (9%) had recently undergone surgery, and one of them developed skin and softprothrombin time. Antimicrobial therapy was considered to be appropriate if one or more antimicrobial agents were active in tissue infection. Four patients (9%) had received respiratory assistance, but none of them developed pneumonia. All 43 vitro against the corresponding isolate when the agent(s) was given at an adequate dosage via an appropriate route. Death patients had intravascular catheters implanted, including one with surgically implanted catheters and 42 with central venous was considered to be related to bacteremia if the patient was being treated simultaneously for bacteremia, unless clinical and catheters (n Å 9) or peripheral lines (n Å 33) that had been placed in the usual manner; three of the 43 patients developed pathological data clearly suggested otherwise.
Bacterial isolates and antimicrobial susceptibility testing. intravascular device -associated infection. The portals of entry for K. oxytoca were clinically and/or Blood specimens of the patients were processed with use of the BACTEC NR 660 blood culture system (Becton-Dickinson, microbiologically determined in 33 cases (77%). In decreasing order of frequency, these portals of entry were the hepatoSparks, MD) in BACTEC 6A and 7A media. Organisms were identified by the conventional methods [9] . Antimicrobial susbiliary tract (58%), an intravascular catheter (7%), the urinary tract (5%), the skin and soft tissues (5%), and the peritoneal ceptibility testing of the isolates was done with use of the Kirby-Bauer disk diffusion method [10] .
cavity (2%). The clinical manifestations of K. oxytoca bacteremia in these patients are summarized in table 2. Twenty-one patients (49%) Results had jaundice, which manifested as biliary tract infection in 16 (76%). Eight patients (19%) developed shock, and four (50%) Clinical features. During the 16-year period, we identified 43 patients who had had an episode of K. oxytoca bacteremia.
of these patients had clinical manifestations of biliary tract infection. All six patients (14%) with leukopenia had received These cases constituted Ç3.7% of episodes of klebsiella bacteremia, 0.67% of episodes of bacteremia due to aerobic gramchemotherapy for underlying hematologic neoplasms. Ten patients (23%) had thrombocytopenia; in eight (80%) of these negative rods, and 0.39% of the total episodes of bacteremia during the study period.
patients, thrombocytopenia manifested as primary bacteremia or biliary tract infection. DIC, which occurred in one patient Sixty-three percent of the cases of bacteremia were community acquired, and 37% were nosocomial in origin. Of the 43 (2%), manifested as biliary tract infection. More cases of hepatobiliary stones and fewer cases of neopatients, 63% had monomicrobial bacteremia, and the remaining 37% had polymicrobial bacteremia due to K. oxytoca plastic disease were noted among patients with communityacquired bacteremia than among those with nosocomial bacteras well as other organisms. The accompanying microorganisms were, in decreasing order of frequency, Escherichia coli emia (tables 1 and 2). No significant differences with respect / 9c2f$$ju15 05-06-97 22:13:04 cida UC: CID (9) * P õ .01. † Includes acute myelogenous leukemia (4 patients), chronic myelogenous leukemia (1), and acute lymphoblastic leukemia (1). ‡ Includes esophageal cancer (2 patients); hepatoma (4); gastric cancer (2); and cholangiocarcinoma, pancreatic cancer, prostate cancer, and metastatic adenocarcinoma of unknown origin (1 each).
to the parameters listed in tables 1 and 2 were noted between with either b-lactam antibiotics (n Å 11) or an aminoglycoside (n Å 1) alone, and 31 patients received combination patients with monomicrobial bacteremia and those with polymicrobial bacteremia.
therapy with b-lactam antibiotics and aminoglycosides. All 12 patients receiving monotherapy were immunocompetent Identification of isolates. All 43 isolates were identified as Klebsiella species by conventional methods, and all produced and did not develop septic shock. Klebsiella bacteremia manifested as biliary tract infection in eight patients and as uriindole, indicating that they were K. oxytoca. Thirty-three (77%) of these 43 patients had at least two sets of blood cultures nary tract infection in two of these 12 patients. The patient infected with the multiresistant isolate was treated with ampositive for this organism.
Antimicrobial susceptibilities. All isolates were susceppicillin/sulbactam. All patients who developed septic shock were treated with tible to ampicillin/sulbactam, cefmetazole, imipenem, aminoglycosides, and quinolones but were resistant to ampia b-lactam in combination with an aminoglycoside. Twelve of 18 patients with hepatobiliary stones underwent surgical recillin (table 3). Susceptibility to cefazolin was variable (86% of isolates). One isolate (2%) was resistant to ampicillin, moval of the stones, and there was no significant difference in outcome between patients who did or did not undergo surgical cefazolin, cefotiam, cefotaxime, and aztreonam. Susceptibilities to ticarcillin and piperacillin were available for 10 isointervention. Four (9%) of the 43 patients did not respond to antimicrobial therapy because they developed advanced septic lates; all were resistant to ticarcillin, and five (50%) were resistant to piperacillin. There was no statistical difference shock; these patients died. The remaining patients responded to the therapy and survived. The four patients who died of in terms of antimicrobial susceptibilities between isolates from patients with community-acquired infection and those septic shock had been treated with combination therapy; these patients included two with community-acquired bacteremia and with nosocomial infection (P ú .05).
Treatment and outcomes. All patients were treated with two with nosocomial bacteremia (three of the four patients had monomicrobial bacteremia, and one had polymicrobial bacterappropriate antibiotics on the basis of the in vitro susceptibility results. Twelve patients (28%) received monotherapy emia).
/ 9c2f$$ju15 05-06-97 22:13:04 cida UC: CID Discussion gram-positive bacteremia. In contrast to most previous investigators [12, 17, 18] , who have described klebsiella bacKlebsiella species are a leading cause of gram-negative teremia as typically nosocomial in origin, we found that bacteremia, ranking second only to E. coli [1, 11 -16] . In approximately two of every three episodes of K. oxytoca our hospital, Klebsiella was the second principal cause of bacteremia were community acquired. Our results are similar gram-negative bacteremia and the third principal cause of to those of one study of K. pneumoniae bacteremia in Taiwan [19] ; the reason for this is not yet known. Although the investigators in that study [19] reported that the increased The incidence of polymicrobial bacteremia (37%) in our Piperacillin † 5 (50) study was higher than that in previous reports [3, 19, 20] previous reports on klebsiella bacteremia [3, 19] .
Amikacin 43 (100)
The urinary, respiratory, and gastrointestinal tracts have been Aztreonam 42 (98) reported as being the predominate portals of entry for klebsiella Imipenem 43 (100) bacteremia [3, 6, 12, 17, 21] . In our experience, the predomiCiprofloxacin 43 (100) nance of the hepatobiliary tract (58%) as the portal of entry Ofloxacin 43 (100) Nalidixic acid 43 (100) for K. oxytoca bacteremia was remarkable, especially among patients (70%) with community-acquired bacteremia. About * Determined by the disk diffusion method.
one-fourth of our patients had primary bacteremia, a finding † Susceptibilities to ticarcillin and piperacillin were available for only 10 isolates.
that is in agreement with the findings of other investigators / 9c2f$$ju15 05-06-97 22:13:04 cida UC: CID [1, 3, 19, 22] . In our study, the intravascular catheters and the commonly used antibiotics, and was associated with a lower mortality rate. urinary tract were also important origins of bacteremia, as have been described in other studies of klebsiella bacteremia [3, 17, 22] .
The clinical manifestations of K. oxytoca bacteremia are
